Abstract
Genetically encoded, light activatable proteins furnish the means to probe biochemical pathways at specific sub-cellular locations with exquisite temporal control. However, engineering these systems to provide a dramatic jump in localized activity while retaining a low dark-state background remains a significant challenge. We describe herein an actin-remodelling protein cofilin that, when placed within the framework of a genetically encodable, light activatable heterodimerizer system, induces dramatic changes in the F-actin network and consequent cell motility upon illumination. We demonstrate that the use of a partially impaired mutant of cofilin is critical for maintaining low background activity in the dark. We also show that light-directed recruitment of the reduced activity cofilin mutants to the cytoskeleton is sufficient to induce F-actin remodeling, formation of filopodia, and directed cell motility.
Keywords: optogenetics, cofilin, cell motility, F-actin, protein design
Chemical and optogenetic methods for clustering proteins at subcellular locations have flourished in recent years.[1] However, in spite of the promise that optogenetic tools hold for biology and medicine,[2] their ready application is constrained by “protein engineering strategies that unfortunately remain in [the] development stage”.[3] Engineering challenges include the high levels of dark (background) activity that inadvertently up- or down-regulate genes and biochemical pathways of interest. Several strategies have been described to address these issues, including protein sequestration and subsequent release,[4] the use of split protein constructs that are only active upon reconstitution,[5] and the application of nonsense suppression technology to introduce non-standard amino acids[6]. Each of these strategies offers elegant solutions to the construction of light-activated proteins. However, these methods require a level of biochemical and cellular engineering that is beyond the expertise typically available in most biology labs.
We describe herein an optogenetic engineering approach that draws its inspiration from the Michaelis-Menten equation (v0 = kcat[E][S]/(Km + [S]). In particular, the latter asserts the dependence of catalytic rate on both the intrinsic kcat of the enzyme as well as its concentration.[7] An enzyme with significantly impaired activity could have the reaction velocity restored by concentrating the catalyst in a spatially well-defined fashion. If the latter were achieved in a light-mediated manner then activity in the dark should be minimal whereas activity upon illumination could equal that of wild type protein (Scheme 1). Indeed, this strategy should prove applicable to any protein, whether or not it's a catalyst, as long as its activity can be controlled in a concentration dependent fashion.
Scheme 1.

General strategy for the design of a genetically encoded light-activatable protein. A weakly active cofilin mutant (black) is appended to the light-responsive Cry2 (blue). In the absence of light, the cofilin construct has no discernable effect on the cytoskeleton. Upon illumination at 488 nm, Cry2 associates with F-actin-bound Cib (green), furnishing a high effective cofilin concentration, thereby promoting F-actin severing, cytoskeleton remodelling, lamellipodia formation and directed cell motility.
Building upon previous work that examined the structure-function relationships of cofilin, we introduced D94A, S120A, K96Q mutations which are known to impair cofilin’s F-actin binding, severing, and depolymerizing activity (Supplemental Figure 1a).[8] In addition, we introduced an Ala-for-Ser mutation at the S3 position to ensure that cofilin cannot be intracellularly “turned off” via phosphorylation.[9] In short, we anticipated that a constitutively active cofilin (S3A) with poor F-actin affinity and reduced F-actin severing (D94A, S120A, K96Q) should display a higher concentration threshold for efficient F-actin severing and depolymerization relative to wild type cofilin [Table 1; Supplemental Figures 1(b,c) and 2].
Table 1.
Summary of actin-pyrene assays of cofilin single and double mutants at indicated cofilin concentrations where “−“ = no severing; “+” = weak severing; “++” = moderate severing; “+++” = strong severing; n.d. = not determined. See Supplemental Figures 1 and 2 for real time plots.
| [Cofilin] μM |
WT | S3E | S3A | S3A S120A |
S3A D94A |
S3A K96Q |
|---|---|---|---|---|---|---|
| 0.2 | ++ | − | ++ | − | − | − |
| 0.5 | +++ | − | +++ | + | − | − |
| 1 | +++ | − | +++ | ++ | − | − |
| 5 | n.d. | + | n.d. | +++ | + | ++ |
| 10 | n.d. | ++ | n.d. | +++ | + | +++ |
| 20 | n.d. | ++ | n.d. | +++ | + | +++ |
| 40 | n.d. | ++ | n.d. | +++ | + | +++ |
The activity of the isolated S3A/D94A, S3A/S120A, and S3A/K96Q proteins was assessed using a pyrene-labelled actin assay.[10] The S3A/S120A double mutant displays an order of magnitude minimal to maximal activity range (0.2 - 5 μM, Table 1). This dynamic range recapitulates the minimal activity displayed by disabled S3E cofilin and the robust activity exhibited by constitutively active S3A cofilin. Although the other double mutants, S3A/D94A and S3A/K96Q, display concentration-dependent F-actin remodelling, neither are as active as S3A/S120A construct. We confirmed that the reduced activity of these cofilin mutants is due, at least in part, to reduced F-actin binding affinity (Supplemental Figure 1c).
We subsequently incorporated fully active S3A cofilin and its activity compromised counterparts into a light activatable dimerizer system, cryptochrome 2 – Cib (Cry2-Cib) (Scheme 1).[1b] This light responsive construct enjoys the advantage of rapid blue light (488 nm) activated dimerization. A fluorescent Cib construct that is anchored to F-actin was prepared: LifeAct-Cib-GFP. The LifeAct component is efficiently incorporated into the F-actin network and has little effect on actin dynamics.[11] The other half of the light-induced dimerizer system is comprised of a fully active truncated form of Cry2 fused to mCherry (Cry2-mCh) (Scheme 1), which is homogeneously distributed throughout the cytoplasm in the dark. However, upon illumination, Cry2-mCh rapidly translocates to the F-actin network in REF52, Cos7, and MTLn3 cells (Figure 1, Supplemental Movie 1). Upon cessation of illumination, Cry2-mCh fully dissociates from F-actin within 6 min (Supplemental Figure 3a). Consequently, the construct is both light activatable and dark-reversible.
Figure 1.

Visualization of light-mediated (488 nm laser, 400 ms pulse, 10% laser power) Cry2-mCh recruitment to LifeAct-Cib-GFP/F-actin in (a) REF52, (b) COS-7, and (c) MTLn3 cells. (i) pre-illumination imaging of Cry2-mCh demonstrates that the construct is distributed throughout the cytoplasm, (ii) post-illumination (10 s) imaging of Cry2-mCh shows accumulation at F-actin as assessed by (iii) imaging of LifeAct-Cib-GFP. Pearson’s coefficient of (ii) and (iii) is (a) 0.93 ± 0.02, (b) 0.96 ± 0.03, and (c) 0.93 ± 0.03; n = 8. Scale bar = 10 μm.
With the light sensitive dimerizer in hand, fully functional and reduced activity cofilin constructs were appended to the N and C termini of the Cry2-mCh scaffold (Scheme 1; Supplemental Figure 3b). We initially characterized these Cof-Cry2 fusions using whole cell illumination to visualize cofilin recruitment to F-actin in MtLn3 cells. These experiments revealed that all the cofilin constructs exhibit a rapid light-induced translocation to the cytoskeleton, but with varied F-actin residence times: CofS3A-Cry2-mCh < CofS3A.S120A-Cry2-mCh < CofS3E-Cry2-mCh (Supplemental Figures 3c-d). The intracellular F-actin residence time inversely correlates with the activity of the cofilin mutant, implying that the actin binding and severing/depolymerizing activity of the cofilin constructs play a role in the rate of dissociation of the dimer pair. The C-terminal cofilin mutants exhibit a similar trend, with the F-actin residence time inversely mirroring the activity of the cofilin mutant.
Co-transfection of MTLn3 cells with the Cof-Cry2-mCh constructs and LifeAct-mTurq2 (to visualize the F-actin network) revealed that the wild type and the constitutively active S3A mutant bind to the cortical F-actin network and other F-actin-rich structures in the dark (Figure 2a-b). By contrast, the partially impaired S3A.S120A construct and the significantly impaired S3E construct do not associate with F-actin in the absence of illumination (Figure 2c and Supplemental Figure 4). This is consistent with the known inability of the S3E mutant to associate with the actin network.[12] These results demonstrate that, in the dark, fully active constructs impact cytoskeletal dynamics whereas functionally impaired cofilin mutants do not.
Figure 2.
Interaction of Cof-Cry2-mCh constructs with F-actin in the dark (“background activity”) in MTLn3 cells. (a) Cof(WT)-Cry2-mCh, (b) CofS3A-Cry2-mCh, and (c) CofS3A.S120A-Cry2-mCh. See Supplementary Figure 4 for CofS3E-Cry2-mCh. (i) Cof-Cry2-mCh distribution, (ii) F-actin distribution imaged via LifeAct-mTurq2, and (iii) overlay highlighting co-localization (green) between the cofilin constructs and F-actin. (a) and (b) display significant co-localization (green) whereas (c) and the S3E construct (Supplemental Figure 4) do not. Scale bar = 5 μm.
We subsequently carried out global illumination experiments of MTLn3 cells to assess the consequences of cofilin recruitment on the F-actin network. MTLn3 cells were simultaneously imaged and stimulated via illumination at 488 nm once every min over a 10 min time course using a confocal microscope at a scan rate of 4 μsec/pixel. Cells containing the CofS3A.S120A-Cry2-mCh construct display a 10% expansion in cell area upon illumination (Supplemental Figure 5), which is consistent with earlier studies showing that up-regulation of cofilin activity (by epidermal growth factor) induces cell spreading.[13] By contrast, cells with the control Cry2-mCh construct exhibit a slight global retraction. Additional global illumination experiments were conducted with a widefield microscope in order to capture all the changes at the cell periphery. This revealed the formation of numerous filopodia upon cofilin recruitment (Figure 3), a response similar to that produced by treating MTLn3 cells with EGF,[14] which is known to up-regulate cofilin activity.[10a]
Figure 3. Cofilin-induced filopodia in MTLn3 cells.

(a) The F-actin network of an MTLn3 cell transfected with CofS3A.S120A-Cry2-mCh/LifeAct-Cib-GFP (left) prior to and (right) 10 min after illumination. (b) The F-actin network of a Cry2-mCh/LifeAct-Cib-GFP transfected MTLn3 cell (left) prior to and (right) 10 min after illumination. Numerous filopodia were formed in the cofilin-transfected cells following light stimulation [highlighted in (a)]. Eight cells total were examined with the above light exposure protocol and filopodia counted at prior to and following illumination. Cofilin-expressing cells have a mean 4-fold increase in filopodia (3.6 ± 0.8)** while control cells exhibit a negligible change in filopodial structures (1.3 ± 0.2) n = 10; **p = 0.001, one way ANOVA. See Supporting Figure 6 for a close-up image of filopodia.
Previous work has demonstrated that cofilin induces localized lamellipodia formation and defines the direction of cell movement.[9a, 12] We utilized brief (100 ms), spatially restricted pulses of light to induce localized recruitment of cofilin to F-actin near the leading edge of the cell (Figure 4a and Supplemental Figure 7). In response to local recruitment of cofilin, cells display rapid lamellipodia formation and an increase in lamellipodia/lamella area (within 30 s of stimulus). In contrast, MtLn3 cells containing control constructs (Cry2-mCh) exhibit random walking behaviour, little or no lamellipodia formation, and a slight decrease in lamellipodia/lamella area encompassing the site of illumination (Figure 4b and Supplemental Figure 7). Finally, we employed multiple light pulses to repeatedly recruit cofilin to F-actin and thereby stimulate cell movement over longer distances (Supplemental Movie 2).
Figure 4.

Localized recruitment of cofilin induces protrusive behavior. (a) Localized illumination of S3A.S120ACof-Cry2-mCh/LifeAct-Cib-GFP-containing MTLn3 cells results in lamellipodia formation in the light illuminated region whereas (b) localized illumination in control cells (Cry2-mCh/LifeAct-Cib-GFP) has little effect. (i) Pre-illumination, (ii) 10 s (note the recruitment of cofilin to F-actin fibers) and (iii) 10 min post-illumination. The illumination site is highlighted in (i). (iv) Cell protrusion (green) and retraction (red). Significant protrusive activity is observed in (a) (iv) at the illumination site whereas very little change is observed in (b) (iv). Scale bar = 10 μm.
The cofilin knock-out in mice is embryonic lethal,[15] and a cofilin knock-down in mammalian cell culture impairs cellular behavior.[16] Consequently, our observation that a genetically expressed photo-responsive cofilin produces discernable cellular effects, even in the presence of endogenous wild type cofilin, provides the means to perturb cofilin activity without compromising viability. Nonetheless, we also examined the cellular consequences of cofilin photo-activation against a reduced wild type cofilin activity background. This was achieved by transfecting CofS3A.S120A-Cry2-mCh-expressing MTLn3 cells with LIM-kinase 1 (LIM-K1), which phosphorylates endogenous cofilin at Ser-3 and thus inactivates cofilin’s ability to bind to and remodel the F-actin cytoskeleton.[9] We note that only endogenous cofilin can be phosphorylated in this fashion since CofS3A.S120A contains a non-phosphorylatable alanine at the S3A position. LIM-K1 expression resulted in a 50% increase in endogenous p-cofilin levels up to approximately 75% of total cofilin content (Supplemental Figure 8). CofS3A.S120A-containing MTLn3 cells, whether or not transfected with LIM-K1, display approximately the same amount of light-induced cell spreading (Supplemental Figure 5c). This implies that the light-responsive CofS3A.S120A construct serves as the dominant remodeler of the actin cytoskeleton under the illumination conditions described in this study.
In summary, we’ve developed a genetically expressed photo-responsive F-actin remodelling system that exhibits light-directed motility. Although the design and engineering of genetically expressed photo-responsive proteins has proven challenging, we’ve found that simply reducing the activity of native cofilin is all the engineering required to create a background-inactive, light activatable construct. We note that a significant cellular response is observed even in the presence of endogenous cofilin. This is fortuitous since it potentially affords the opportunity to create healthy genetically engineered animals in which cofilin action can be subsequently manipulated. For example, recent studies have shown that the invasive and metastatic behavior in breast cancer is driven by the activity of the cofilin pathway.[17] It should now be possible to directly assess the biological consequences of the abrupt hyper-activation of cofilin as a function of timing and location in animal models.
Supplementary Material
Acknowledgements
We thank the NIH for financial support (1R01CA159189). We are grateful to Professor James Bamburg (Colorado State) for helpful discussions regarding the manuscript. MTLn3 cells were a gift from Professor James Bear (UNC). LifeAct-mTurq2 was a gift from Professor Theodorus W. J. Gadella (University of Amsterdam). pNic28-BSA4 was a gift from the Toronto Structural Genomics Consortium.
Bibliography & References Cited
- [1].(a) Goguen BN, Imperiali B. ACS Chem Biol. 2011;6:1164–1174. doi: 10.1021/cb200299k. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Kennedy MJ, Hughes RM, Peteya LA, Schwartz JW, Ehlers MD, Tucker CL. Nat Methods. 2010;7:973–975. doi: 10.1038/nmeth.1524. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Levskaya A, Weiner OD, Lim WA, Voigt CA. Nature. 2009;461:997–1001. doi: 10.1038/nature08446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].(a) Goguen BN, Hoffman BD, Sellers JR, Schwartz MA, Imperiali B. Angewandte Chemie. 2011;50:5667–5670. doi: 10.1002/anie.201100674. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Schroder-Lang S, Schwarzel M, Seifert R, Strunker T, Kateriya S, Looser J, Watanabe M, Kaupp UB, Hegemann P, Nagel G. Nat Methods. 2007;4:39–42. doi: 10.1038/nmeth975. [DOI] [PubMed] [Google Scholar]; (c) Stierl M, Stumpf P, Udwari D, Gueta R, Hagedorn R, Losi A, Gartner W, Petereit L, Efetova M, Schwarzel M, Oertner TG, Nagel G, Hegemann P. J Biol Chem. 2011;286:1181–1188. doi: 10.1074/jbc.M110.185496. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Wu YI, Frey D, Lungu OI, Jaehrig A, Schlichting I, Kuhlman B, Hahn KM. Nature. 2009;461:104–108. doi: 10.1038/nature08241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Yin T, Wu YI. Pflugers Archiv : European journal of physiology. 2013;465:397–408. doi: 10.1007/s00424-013-1244-x. [DOI] [PubMed] [Google Scholar]
- [4].Chen D, Gibson ES, J. Kennedy M. J Cell Biol. 2013;201:631–640. doi: 10.1083/jcb.201210119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].(a) Shekhawat SS, Ghosh I. Curr Opin Chem Biol. 2011;15:789–797. doi: 10.1016/j.cbpa.2011.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Camacho-Soto K, Castillo-Montoya J, Tye B, Ghosh I. J Am Chem Soc. 2014;136:3995–4002. doi: 10.1021/ja4130803. [DOI] [PubMed] [Google Scholar]
- [6].(a) Gautier A, Deiters A, Chin JW. J Am Chem Soc. 2011;133:2124–2127. doi: 10.1021/ja1109979. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Riggsbee CW, Deiters A. Trends in biotechnology. 2010;28:468–475. doi: 10.1016/j.tibtech.2010.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Michaelis L, Menten MM. FEBS letters. 2013;587:2712–2720. doi: 10.1016/j.febslet.2013.07.015. [DOI] [PubMed] [Google Scholar]
- [8].Moriyama K, Yahara I. Biochem J. 2002;365:147–155. doi: 10.1042/bj20020231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].(a) Ghosh M, Song X, Mouneimne G, Sidani M, Lawrence DS, Condeelis JS. Science. 2004;304:743–746. doi: 10.1126/science.1094561. [DOI] [PubMed] [Google Scholar]; (b) Moriyama K, Iida K, Yahara I. Genes Cells. 1996;1:73–86. doi: 10.1046/j.1365-2443.1996.05005.x. [DOI] [PubMed] [Google Scholar]; (c) Pope BJ, Gonsior SM, Yeoh S, McGough A, Weeds AG. J Mol Biol. 2000;298:649–661. doi: 10.1006/jmbi.2000.3688. [DOI] [PubMed] [Google Scholar]
- [10].(a) Sidani M, Wessels D, Mouneimne G, Ghosh M, Goswami S, Sarmiento C, Wang W, Kuhl S, El-Sibai M, Backer JM, Eddy R, Soll D, Condeelis J. J Cell Biol. 2007;179:777–791. doi: 10.1083/jcb.200707009. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Doolittle LK, Rosen MK, Padrick SB. Methods in molecular biology. 2013;1046:273–293. doi: 10.1007/978-1-62703-538-5_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Riedl J, Crevenna AH, Kessenbrock K, Yu JH, Neukirchen D, Bista M, Bradke F, Jenne D, Holak TA, Werb Z, Sixt M, Wedlich-Soldner R. Nat Methods. 2008;5:605–607. doi: 10.1038/nmeth.1220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Vitriol EA, Wise AL, Berginski ME, Bamburg JR, Zheng JQ. Mol Biol Cell. 2013;24:2238–2247. doi: 10.1091/mbc.E13-03-0156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Song X, Chen X, Yamaguchi H, Mouneimne G, Condeelis JS, Eddy RJ. Journal of cell science. 2006;119:2871–2881. doi: 10.1242/jcs.03017. [DOI] [PubMed] [Google Scholar]
- [14].Lichtner RB, Wiedemuth M, Noeske-Jungblut C, Schirrmacher V. Clin Exp Metastasis. 1993;11:113–125. doi: 10.1007/BF00880072. [DOI] [PubMed] [Google Scholar]
- [15].Gurniak CB, Perlas E, Witke W. Developmental biology. 2005;278:231–241. doi: 10.1016/j.ydbio.2004.11.010. [DOI] [PubMed] [Google Scholar]
- [16].von Blume J, Duran JM, Forlanelli E, Alleaume AM, Egorov M, Polishchuk R, Molina H, Malhotra V. J Cell Biol. 2009;187:1055–1069. doi: 10.1083/jcb.200908040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Wang W, Eddy R, Condeelis J. Nature reviews. Cancer. 2007;7:429–440. doi: 10.1038/nrc2148. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

